BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 16715961)

  • 1. Divergent cytotoxic effects of PKC412 in combination with conventional antileukemic agents in FLT3 mutation-positive versus -negative leukemia cell lines.
    Furukawa Y; Vu HA; Akutsu M; Odgerel T; Izumi T; Tsunoda S; Matsuo Y; Kirito K; Sato Y; Mano H; Kano Y
    Leukemia; 2007 May; 21(5):1005-14. PubMed ID: 17330105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The present status of, and problems with the development of FLT3 kinase inhibitors].
    Kiyoi H
    Rinsho Ketsueki; 2006 Apr; 47(4):270-7. PubMed ID: 16715961
    [No Abstract]   [Full Text] [Related]  

  • 3. [FLT3 kinase inhibitors for the treatment of acute leukemia].
    Kiyoi H
    Rinsho Ketsueki; 2010 Jun; 51(6):384-9. PubMed ID: 20622483
    [No Abstract]   [Full Text] [Related]  

  • 4. [Possibility of targeting FLT3 kinase for the treatment of leukemia].
    Kiyoi H
    Rinsho Ketsueki; 2005 Mar; 46(3):187-97. PubMed ID: 16447713
    [No Abstract]   [Full Text] [Related]  

  • 5. [Novel molecularly target therapies for leukemia].
    Kiyoi H
    Nihon Rinsho; 2007 Jan; 65 Suppl 1():611-6. PubMed ID: 17474469
    [No Abstract]   [Full Text] [Related]  

  • 6. Can FLT3 inhibitors overcome resistance in AML?
    Tam WF; Gary Gilliland D
    Best Pract Res Clin Haematol; 2008 Mar; 21(1):13-20. PubMed ID: 18342808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Midostaurin for patients with acute myeloid leukemia and FLT3 mutations.
    Levis MJ
    Clin Adv Hematol Oncol; 2019 Jun; 17(6):323-325. PubMed ID: 31437132
    [No Abstract]   [Full Text] [Related]  

  • 8. Targeting the FMS-like tyrosine kinase 3 in acute myeloid leukemia.
    Swords R; Freeman C; Giles F
    Leukemia; 2012 Oct; 26(10):2176-85. PubMed ID: 22614177
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.